QuietMIND Foundation is a public non-profit research foundation and an outpatient healthcare practice. We provide neurofeedback therapy within the Great Philadelphia region. Our staff includes internationally recognized, highly-trained, professionals drawn from the fields of biofeedback and neuropsychology, neurophysiology, functional medicine, neuropsychiatry, neuroscience research, organizational consulting, and the law.
We also rely on the skills of staff and professionally trained volunteers to design and deliver our marketing and advertising campaigns, and perform some of our administrative functions. We have a national and worldwide network of professionals we consult with to assist us. We actively train and involve our interns in the fundamental work necessary for developing and conducting applied clinical research projects including writing grant proposals, educational programs and maintaining our library and institutional contacts.
We also rely on the skills of staff and professionally trained volunteers to design and deliver our marketing and advertising campaigns, and perform some of our administrative functions. We have a national and worldwide network of professionals we consult with to assist us. We actively train and involve our interns in the fundamental work necessary for developing and conducting applied clinical research projects including writing grant proposals, educational programs and maintaining our library and institutional contacts.
|
|
Marvin H. Berman, Ph.D., C.B.T., Founder & President
Dr. Berman earned his Master’s and PhD in Psychoeducational Processes from Temple University, where he studied group and organizational behavior. He obtained certification in Bioenergetic Analysis at the Philadelphia Institute for Bioenergetic Analysis in 1983. He has participated in post-graduate training workshops and seminars in Systems-Centered Therapy, and the Feldenkrais Method. He was certified in EEG biofeedback in 2003.
Dr. Berman currently consults to senior executives and management teams on the application of cognitive neuroscience in leadership development and performance. He has often consulted on issues regarding team development, group relations, and organizational culture. He has taken a leadership role in expanding the application of EEG biofeedback and related technologies into the treatment of and neurodegenerative and neuropsychiatric disorders.
James P. Halper, M.D., Medical Director
Dr. Halper is a (NY, NJ, PA) licensed, board certified psychiatrist, immunologist and internist with a specialization in immunology and neuropsychiatry. He is on the clinical faculty of the Dept. of Psychiatry at New York University and has been a pioneer in the field of neuropsychiatry. Dr. Halper consults internationally and is conducting research on the integration of QEEG assessment to improve the efficacy of rTMS treatment for depression.
Allan Spiegel, MD, Director of Clinical Neurology
Dr. Spiegel is Board certified in Neurology (PA, TN, Fl) and an internationally recognized expert in hyperbaric oxygen therapy. Dr. Spiegel serves as the supervising physician for clinical trials on the use of near infrared stimulation in the treatment of Parkinson's disease and oversees the Quantitative EEG assessment service at QuietMIND Foundation.
Neal M. Stolar, M.D., Ph.D., Integrative Psychiatry Director
Dr. Stolar earned his MD-PhD University of Illinois - Urbana-Champaign and is on the staff at Chester-Crozer Hospital. He's been recognized by the National Alliance for Mental Illness of Pennsylvania for his scholarship and research in the area of schizophrenia. He is working on developing innovative models for combining psychotherapy and neuromodulation in the treatment of psychosis.
Allan Lundy, Ph.D., IRB Chairman
Dr Lundy earned his PhD in Social Psychology from Harvard University in 1981. Between 1992 and 2003 he was on the faculty of the Department of Psychiatry at Jefferson Medical College. During that time, he published 32 articles and book chapters. In his last six years at Jefferson he was Principal Investigator on NIH and other grants totaling over two million dollars. Since 2003 he has been an independent consultant in research methods and statistical analysis.
Eric Miller, Ph.D., Consulting Music & Neurofeedback Therapist
Dr. Miller is an internationally recognized expert on the integration of music therapy and biofeedback with a variety of clinical populations. Dr. Miller has also created the Biofeedback Network, a highly regarded internet portal for biofeedback related information and treatment resources. Dr. Miller has consulted on a number of QMF clinical trials and provides ongoing technical support and guidance to our interns and trainees.
Scott Berman, B.A., Community Outreach and Development.
Scott has taken responsibility for studying and developing marketing strategies for a range of innovative therapeutic technologies that can enhance neurofeedback and other treatment approaches we employ. He is also helping to promote the foundation's work within the Philadelphia philanthropic community.
Dr. Berman earned his Master’s and PhD in Psychoeducational Processes from Temple University, where he studied group and organizational behavior. He obtained certification in Bioenergetic Analysis at the Philadelphia Institute for Bioenergetic Analysis in 1983. He has participated in post-graduate training workshops and seminars in Systems-Centered Therapy, and the Feldenkrais Method. He was certified in EEG biofeedback in 2003.
Dr. Berman currently consults to senior executives and management teams on the application of cognitive neuroscience in leadership development and performance. He has often consulted on issues regarding team development, group relations, and organizational culture. He has taken a leadership role in expanding the application of EEG biofeedback and related technologies into the treatment of and neurodegenerative and neuropsychiatric disorders.
James P. Halper, M.D., Medical Director
Dr. Halper is a (NY, NJ, PA) licensed, board certified psychiatrist, immunologist and internist with a specialization in immunology and neuropsychiatry. He is on the clinical faculty of the Dept. of Psychiatry at New York University and has been a pioneer in the field of neuropsychiatry. Dr. Halper consults internationally and is conducting research on the integration of QEEG assessment to improve the efficacy of rTMS treatment for depression.
Allan Spiegel, MD, Director of Clinical Neurology
Dr. Spiegel is Board certified in Neurology (PA, TN, Fl) and an internationally recognized expert in hyperbaric oxygen therapy. Dr. Spiegel serves as the supervising physician for clinical trials on the use of near infrared stimulation in the treatment of Parkinson's disease and oversees the Quantitative EEG assessment service at QuietMIND Foundation.
Neal M. Stolar, M.D., Ph.D., Integrative Psychiatry Director
Dr. Stolar earned his MD-PhD University of Illinois - Urbana-Champaign and is on the staff at Chester-Crozer Hospital. He's been recognized by the National Alliance for Mental Illness of Pennsylvania for his scholarship and research in the area of schizophrenia. He is working on developing innovative models for combining psychotherapy and neuromodulation in the treatment of psychosis.
Allan Lundy, Ph.D., IRB Chairman
Dr Lundy earned his PhD in Social Psychology from Harvard University in 1981. Between 1992 and 2003 he was on the faculty of the Department of Psychiatry at Jefferson Medical College. During that time, he published 32 articles and book chapters. In his last six years at Jefferson he was Principal Investigator on NIH and other grants totaling over two million dollars. Since 2003 he has been an independent consultant in research methods and statistical analysis.
Eric Miller, Ph.D., Consulting Music & Neurofeedback Therapist
Dr. Miller is an internationally recognized expert on the integration of music therapy and biofeedback with a variety of clinical populations. Dr. Miller has also created the Biofeedback Network, a highly regarded internet portal for biofeedback related information and treatment resources. Dr. Miller has consulted on a number of QMF clinical trials and provides ongoing technical support and guidance to our interns and trainees.
Scott Berman, B.A., Community Outreach and Development.
Scott has taken responsibility for studying and developing marketing strategies for a range of innovative therapeutic technologies that can enhance neurofeedback and other treatment approaches we employ. He is also helping to promote the foundation's work within the Philadelphia philanthropic community.